Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘exicure’

Exicure to Present at BIO CEO & Investor Conference 2019

Posted by fidest press agency su venerdì, 8 febbraio 2019

Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CEO, Dr. David Giljohann, will present a corporate update on Monday, February 11, 2019 at 11:15 am EST at the BIO CEO & Investor Conference. The presentation will be in the Hudson/Empire room at the New York Marriott Marquis in New York City.A live audio webcast will be available on the Investors section of Exicure’s website: http://www.exicuretx.com. The webcast will be archived for approximately 30 days following the event.
Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure’s proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure’s lead programs address inflammatory diseases, genetic disorders and oncology. Exicure is based outside of Chicago, IL. http://www.exicuretx.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »